The newest addition to Epicutis’s science-based professional skincare line, which the company says treats skin health and not age, is the Arctigenin Brightening Treatment—a clean, clinically proven skin brightening treatment that Epicutis says dethrones Vitamin C as the reigning brightening superpower.
The company said in a press release that the new treatment was developed with cutting-edge biotechnology methods and harnesses the power of Epicutis’ proprietary botanical Burdock extract enriched for high levels of Arctigenin to offer a safe and effective alternative to traditional brightening ingredients such as Vitamin C, Kojic Acid, and Niacinamide products, directly addressing the shortcomings of these methods.
Epicutis founder and CEO Maxwell Stock noted in the press release that Vitamin C is most commonly found in the form of L-ascorbic acid, which is highly unstable when exposed to oxygen.
“With our new patented ingredient, Arctiginen, we are able to create a more stable and effective brightening solution,” Stock said in the press release.
Arctigenin, derived from burdock seed, works synergistically with HYVIA® and Canadian white pine bark to provide a comprehensive brightening solution. This unique formulation ensures that the active ingredients are infused deeply into the skin, maximizing their brightening and spot-reducing benefits.
“Brightening the skin safely is one of the foremost challenges in dermatology,” James Wang, MD, double-board certified dermatologist and founder of Metropolis Dermatology, said in the press release. “Although there are skincare options for brightening, such as Vitamin C, Kojic Acid, and Arbutin, results have been generally underwhelming. In fact, there have been few advances since the eighties that have yielded meaningful outcomes.”
